PCA
GDRX icon

Pallas Capital Advisors’s GoodRx Holdings GDRX Stock Holding History

Pallas Capital Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.9K Buy
22,526
+10,758
+91% +$27.3K ﹤0.01% 978
2026
Q1 		$23.1K Buy
+11,768
New +$27.6K ﹤0.01% 850

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PTC
Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Pallas Capital Advisors's GDRX Position: Q2 2026 in Review

Pallas Capital Advisors increased its GoodRx Holdings (GDRX) stake by 91% in Q2 2026, buying an estimated $27.3K and bringing the position to 22,526 shares worth $64.9K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

Pallas Capital Advisors first reported a position in GDRX in Q1 2026 and has held it in 2 quarters since. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Pallas Capital Advisors held 22,526 shares of GoodRx Holdings worth $64.9K as of Q2 2026.
  • Pallas Capital Advisors bought 10,758 GoodRx Holdings shares in Q2 2026, an estimated $27.3K.
  • GoodRx Holdings made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #978 holding.
  • Pallas Capital Advisors first reported a position in GoodRx Holdings in Q1 2026 and has held it in 2 quarters since.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.